Sarcoma

SJR Rank #10,597H-index: 57SJR: 0.560Best quartile: Q2Open AccessAPC: US$820
Journal website: aims, scope and author guidelines
Publisher

John Wiley and Sons Ltd

Country

United States

Type

journal

SJR by Edition

2022202500.150.30.450.6

Subject Categories

  • Radiology, Nuclear Medicine and ImagingQ2
  • OncologyQ3

Areas: Medicine

Most published research topics

Sarcoma Diagnosis and TreatmentBone Tumor Diagnosis and TreatmentsVascular Tumors and AngiosarcomasCardiac tumors and thrombiManagement of metastatic bone diseaseLymphoma Diagnosis and TreatmentSoft tissue tumor case studiesMusculoskeletal synovial abnormalities and treatmentsOral and Maxillofacial PathologySoft tissue tumors and treatment

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs07142128

Documents per Year

202220250481216

Detailed Information

ISSN

1357-714X, 1369-1643

SJR Best Quartile

Q2

Region

Northern America

Citations per Document (2 years)

2.90

References per Document

0.00

Coverage

1997-2024

Scope

Sarcoma is dedicated to publishing papers covering all aspects of connective tissue oncology research. It brings together work from scientists and clinicians carrying out a broad range of research in this field, including the basic sciences, molecular biology and pathology and the clinical sciences of epidemiology, surgery, radiotherapy and chemotherapy. High-quality papers concerning the entire range of bone and soft tissue sarcomas in both adults and children, including Kaposi’s sarcoma, are published as well as preclinical and animal studies. This journal provides a central forum for the description of advances in diagnosis, assessment and treatment of this rarely seen, but often mismanaged, group of patients. It is of interest to all those working with bone and soft tissue tumours, including medical, surgical and paediatric oncologists, radiotherapists, pathologists and research scientists.

Metrics from SCImago Journal Rank 2025. View on SCImago